Skip to main content
. 2021 Jul 15;6(5):100751. doi: 10.1016/j.adro.2021.100751

Table 1.

Patient characteristics

Characteristic n = 155% (no.) or median (range)
Age, y 68.2 (24-91)
Sex
 Male 77% (120)
 Female 23% (35)
Race/ethnicity
 White 76% (118)
 Black 0% (0)
 Hispanic 17% (27)
 Other 1% (1)
 Unknown 6% (9)
ECOG
 0 48% (75)
 1-3 37% (58)
 Unknown 14% (22)
Histology
 Adenocarcinoma 77% (120)
 Squamous cell carcinoma 22% (34)
 Other 1% (1)
Grade
 1-2 43% (67)
 3 30% (46)
 Undetermined 27% (42)
Tumor dimension, cm 4.5 (1-10)
 Stage
 I-II 39% (60)
 III-IV 54% (83)
 Unknown 8% (12)
T category
 T1-T2 26% (41)
 T3-T4 60% (93)
 TX 6% (9)
 Unknown 8% (12)
N category
 N0 30% (46)
 N+ 61% (94)
 NX 1% (2)
 Unknown 8% (13)
M category
 M0 75% (116)
 M1 7% (11)
 Unknown 18% (28)
Chemotherapy
 Induction 12% (19)
 Concurrent 88% (137)

Abbreviation: ECOG = Eastern Cooperative Oncology Group.